Arkolith/Insider Trading/TNXP/Form 4

Treco James

DirectorTonix Pharmaceuticals Holding Corp. (TNXP) · full profile →Form 4 · filed May 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 9, 2022Grant(A)2.1M—$02.1M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001387131-22-006014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML